Literature DB >> 30912024

Use of CRISPR/Cas9 for the Modification of the Mouse Genome.

Alexander Klimke1, Steffen Güttler1, Petric Kuballa1, Simone Janzen1, Sonja Ortmann1, Adriano Flora2.   

Abstract

The use of CRISPR/Cas9 to modify the mouse genome has gained immense interest in the past few years since it allows the direct modification of embryos, bypassing the need of labor-intensive procedures for the manipulation of embryonic stem cells. By shortening the overall timelines and reducing the costs for the generation of new genetically modified mouse lines (Li et al., Nat Biotechnol 31: 681-683, 2013), this technology has rapidly become a major tool for in vivo drug discovery applications.

Entities:  

Keywords:  CRISPR/Cas9; Genome editing; In vivo drug discovery; Knock-in; Knockout; Mouse models

Mesh:

Substances:

Year:  2019        PMID: 30912024     DOI: 10.1007/978-1-4939-9145-7_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters.

Authors:  Kun Yan; Jiangpeng Feng; Xing Liu; Hongyun Wang; Qiaohong Li; Jiali Li; Tianmo Xu; Muhammad Sajid; Hafiz Ullah; Li Zhou; Limin Zhou; Yu Chen
Journal:  Front Microbiol       Date:  2021-06-26       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.